ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628139 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628139; 2) Community: the network communities that were significantly associated with the response to NSC 628139; 3) Molecule: the relationships between components within communities and NSC 628139; 4) MDR: the compounds that were significantly associated with the NSC 628139.

NSC Compound Enrichment Correlation
NSC 740504 5,6-Dihydro-6-[3-(2-hydroxyethyl)amino-1-propyl]-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.024108502230778 0.34514773
NSC 740602 Null 0.024108502230778 0.43955292
NSC 744025 diethyl 2-[4-(5-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypentyl)piperazino]ethylphosphonate 0.024108502230778 0.21225465
NSC 749292 3-methoxy-1-nitrosopyrido[3,2:4,5]pyrrolo[1,2-c][1,2,3]benzotriazine 0.024108502230778 0.43975908
NSC 749379 Null 0.024108502230778 0.48635377
NSC 99733 Rheumygin 0.024108502230778 -0.026704301
NSC 12198 Dromostanolone Propionate 0.0241085022307781 0.34539304
NSC 169774 Bromocriptine methanesulfonate 0.0241085022307781 0.4738985
NSC 22348 1H-Naphth[2,3-d]imidazole-4,9-dione, 1-(p-bromophenyl)- 2-methyl- 0.0241085022307781 0.46219061
NSC 254677 Phomazarin 0.0241085022307781 -0.11113619
Total:73  Current:36    [First] [Prev] [Next] [Last]